Brief: Akari Therapeutics Agrees To Sell And Issue In A Private Placement Approximately $1.6 Million ADSS
11/03/2024 22:30
March 11 (Reuters) - Akari Therapeutics PLC AKTX.O :
* AKARI THERAPEUTICS PLC: AGREED TO SELL AND ISSUE IN A
PRIVATE
PLACEMENT APPROXIMATELY $1.6 MILLION ADSS
Source text for Eikon: [ID:http://www.sec.gov/Archives/edgar/data/1541157/000110465924033087/0001104659-24-033087-index.htm
]
Further company coverage: AKTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Akari Therapeutics
See all newsBrief: Akari Therapeutics - Aktx-101 Demonstrates Robust Anti-Tumor Activity In Urothelial Cancer Preclinical Models
UK's Akari Therapeutics Q2 net loss widens on higher R&D for AKTX-101
Akari Therapeutics PLC reports results for the quarter ended June 30 - Earnings Summary
Akari Therapeutics PLC expected to post a loss of $1.40 a share - Earnings Preview
Brief: Akari Therapeutics Enters Strategic Research Collaboration With Whitehawk Therapeutics